Literature DB >> 3683152

The effect of aerobic conditioning on venous pooling in the foot.

W L Kenney1, C G Armstrong.   

Abstract

Nineteen fit college-age men were studied using foot (mid-arch) mercury-in-silastic strain gauge plethysmography before and after an 8-wk aerobic conditioning (running) program. Foot volume changes were followed through two maneuvers: a 15-s Trendelenburg procedure (passive leg elevation with subsequent relaxation in the dependent position) and a 15-s dynamic dorsi-flexion/plantar flexion exercise and subsequent relaxation. The conditioning regimen consisted of running 40 min, 3 d.wk-1 and resulted in a 10% (P less than 0.01) increase in VO2max. Following this regimen, subjects exhibited an increased blood volume drainage during the Trendelenburg procedure (mean delta VT = 3.3 ml.100 ml-1 pre-training, 3.8 ml.100 ml-1 post-training, P less than 0.05), but no significant change in delta VE (2.7 ml.100 ml-1 for all subjects). Muscle pump efficacy, defined as the ratio between delta VE and delta VT, did not change (64%). These data suggest that increased aerobic power via weight-bearing exercise training results in an increased foot venous pooling, but does not affect relative muscle pump function. This apparent increase in vascular pooling may be a physical response to the hypervolemia induced by endurance training, aiding in maintaining the constancy of vascular pressures.

Entities:  

Mesh:

Year:  1987        PMID: 3683152

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  2 in total

1.  Haemodynamics of leg veins during a 30-days-6 degrees head-down bedrest with and without lower body negative pressure.

Authors:  F Louisy; C Gaudin; J M Oppert; A Güell; C Y Guezennec
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

2.  Limb vasodilatory capacity and venous capacitance of trained runners and untrained males.

Authors:  Yati N Boutcher; Stephen H Boutcher
Journal:  Eur J Appl Physiol       Date:  2005-06-15       Impact factor: 3.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.